| 0 |
Humanized Monoclonal Antibody Fragment [EPC] |
1 |
0.0007 |
| 1 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
2 |
0.0002 |
| 2 |
alpha-1 Adrenergic Agonist [EPC] |
1 |
0.0002 |
| 3 |
CD38-directed Cytolytic Antibody [EPC] |
1 |
0.0002 |
| 4 |
Vitamin D2 Analog [EPC] |
1 |
0.0001 |
| 5 |
CD19-directed Chimeric Antigen Receptor [EPC] |
1 |
0.0001 |
| 6 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
9 |
0.0001 |
| 7 |
Anticholinergic [EPC] |
1 |
0.0001 |
| 8 |
Vitamin D Analog [EPC] |
1 |
0.0001 |
| 9 |
Dihydropyridine Calcium Channel Blocker [EPC] |
18 |
0.0001 |
| 10 |
Catecholamine [EPC] |
4 |
0.0000 |
| 11 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 12 |
Bile Acid [EPC] |
1 |
0.0000 |
| 13 |
Typical Antipsychotic [EPC] |
1 |
0.0000 |
| 14 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 15 |
Angiotensin 2 Receptor Blocker [EPC] |
10 |
0.0000 |
| 16 |
Penem Antibacterial [EPC] |
1 |
0.0000 |
| 17 |
HER2/neu Receptor Antagonist [EPC] |
2 |
0.0000 |
| 18 |
Aromatase Inhibitor [EPC] |
3 |
0.0000 |
| 19 |
Cholinergic Muscarinic Antagonist [EPC] |
1 |
0.0000 |
| 20 |
Polyene Antifungal [EPC] |
1 |
0.0000 |
| 21 |
General Anesthetic [EPC] |
1 |
0.0000 |
| 22 |
Protease Inhibitor [EPC] |
1 |
0.0000 |
| 23 |
Insulin [EPC] |
1 |
0.0000 |
| 24 |
beta-Adrenergic Blocker [EPC] |
6 |
0.0000 |
| 25 |
Central alpha-2 Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 26 |
Complement Inhibitor [EPC] |
1 |
0.0000 |
| 27 |
Proteasome Inhibitor [EPC] |
2 |
0.0000 |
| 28 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
2 |
0.0000 |
| 29 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
2 |
0.0000 |
| 30 |
Cytochrome P450 3A Inhibitor [EPC] |
1 |
0.0000 |
| 31 |
Loop Diuretic [EPC] |
7 |
0.0000 |
| 32 |
Platinum-based Drug [EPC] |
4 |
0.0000 |
| 33 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 34 |
Topoisomerase Inhibitor [EPC] |
1 |
0.0000 |
| 35 |
Alkylating Drug [EPC] |
3 |
0.0000 |
| 36 |
Nucleoside Analog Antiviral [EPC] |
1 |
0.0000 |
| 37 |
Xanthine Oxidase Inhibitor [EPC] |
2 |
0.0000 |
| 38 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
2 |
0.0000 |
| 39 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 40 |
Purine Antimetabolite [EPC] |
1 |
0.0000 |
| 41 |
Endothelin Receptor Antagonist [EPC] |
2 |
0.0000 |
| 42 |
5-alpha Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 43 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 44 |
P2Y12 Platelet Inhibitor [EPC] |
1 |
0.0000 |
| 45 |
Fluoroquinolone Antibacterial [EPC] |
1 |
0.0000 |
| 46 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
1 |
0.0000 |
| 47 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 48 |
Phosphodiesterase 5 Inhibitor [EPC] |
1 |
0.0000 |
| 49 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 50 |
Nucleoside Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 51 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 52 |
Corticosteroid [EPC] |
9 |
0.0000 |
| 53 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
9 |
0.0000 |
| 54 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 55 |
CD20-directed Cytolytic Antibody [EPC] |
2 |
0.0000 |
| 56 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 57 |
Kinase Inhibitor [EPC] |
3 |
0.0000 |
| 58 |
Platelet Aggregation Inhibitor [EPC] |
3 |
0.0000 |
| 59 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 60 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 61 |
Benzodiazepine [EPC] |
3 |
0.0000 |
| 62 |
Thalidomide Analog [EPC] |
2 |
0.0000 |
| 63 |
Opioid Agonist [EPC] |
1 |
0.0000 |
| 64 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 65 |
Osmotic Laxative [EPC] |
1 |
0.0000 |
| 66 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 67 |
Folate Analog Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 68 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |
| 69 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |